The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study

Research output: Contribution to journalArticle


AimsAnaemia and iron deficiency are constituents of the cardio-renal syndrome in chronic heart failure (CHF). We investigated the effects of i.v. iron in iron-deficient CHF patients on renal function, and the efficacy and safety of this therapy in patients with renal dysfunction. Methods and resultsThe FAIR-HF trial randomized 459 CHF patients with iron deficiency (ferritin <100 mu g/L, or between 100 and 299 mu g/L if transferrin saturation was <20%): 304 to i.v. ferric carboxymaltose (FCM) and 155 to placebo, and followed-up for 24 weeks. Renal function was assessed at baseline and at weeks 4, 12, and 24, using the estimated glomerular filtration rate (eGFR, mL/min/1.73m(2)), calculated from the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. At baseline, renal function was similar between groups (62.420.6 vs. 62.9 +/- 23.4 mL/min/1.73m(2), FCM vs. placebo). Compared with placebo, treatment with FCM was associated with an increase in eGFR [treatment effect: week 4, 2.11 +/- 1.21 (P = 0.082); week 12, 2.41 +/- 1.33 (P = 0.070); and week 24, 2.98 +/- 1.44 mL/min/1.73m(2) (P = 0.039)]. This effect was seen in all pre-specified subgroups (P > 0.20 for interactions). No interaction between the favourable effects of FCM and baseline renal function was seen for the primary endpoints [improvement in Patient Global Assessment (P = 0.43) and NYHA class (P = 0.37) at 24 weeks]. Safety and adverse event profiles were similar in patients with baseline eGFR <60 and 60 mL/min/1.73m(2). Conclusions<p id="ejhf229-para-0003">Treatment of iron deficiency in CHF patients with i.v. FCM was associated with an improvement in renal function. FCM therapy was effective and safe in CHF patients with renal dysfunction.


  • Piotr Ponikowski
  • Gerasimos Filippatos
  • Josep Comin Colet
  • Ronnie Willenheimer
  • Kenneth Dickstein
  • Thomas Luescher
  • Giedrius Gaudesius
  • Barbara von Eisenhart Rothe
  • Claudio Mori
  • Nicola Greenlaw
  • Ian Ford
  • Iain Macdougall
  • Stefan D. Anker
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cardiac and Cardiovascular Systems


  • Chronic heart failure, Iron deficiency, Renal function, Ferric, carboxymaltose
Original languageEnglish
Pages (from-to)329-339
JournalEuropean Journal of Heart Failure
Issue number3
Publication statusPublished - 2015
Publication categoryResearch

Total downloads

No data available